Infliximab for IPILIMUMAB-Related Colitis-Letter

Clin Cancer Res. 2015 Dec 15;21(24):5642-3. doi: 10.1158/1078-0432.CCR-15-2471.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Colitis / drug therapy*
  • Colitis / etiology*
  • Humans
  • Infliximab / therapeutic use*
  • Ipilimumab
  • Melanoma / complications
  • Melanoma / diagnosis
  • Melanoma / drug therapy
  • Melanoma / mortality
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Ipilimumab
  • Infliximab